INTRODUCTION
L-forms are cell wall-deficient bacteria that have been described and analyzed in many bacterial species (
15,
16,
21,
37,
76). In several studies, a spontaneous conversion of wild-type cells to L-forms under exposure to cell wall-affecting substances was demonstrated (
36,
37,
43). In most cases, L-forms were generated by inhibiting cell wall biosynthesis through β-lactam treatment or by degradation of the intact cell wall using lysozyme (
33,
60). The resulting L-forms are very osmotically sensitive and need osmotic stabilizers (e.g., KCl salt or sucrose) in the medium to survive (
31,
51). L-forms are very diverse in their morphology but are generally resistant to β-lactam antibiotics because they lack a cell wall. Clinically, L-forms of pathogens (e.g.,
Mycobacterium tuberculosis,
Listeria monocytogenes,
Staphylococcus aureus, and
Helicobacter pylori) exhibit resistance to a wide panel of commercially used cell wall antibiotics, including vancomycin, streptomycin, and penicillin (
18,
70,
71). This feature has raised much concern regarding the persistence of pathogenic L-forms capable of evading classical antibiotic therapy (
43).
In this study, we used the rod-shaped Gram-positive model bacterium
Bacillus subtilis and derived L-forms, which had already been well characterized (
9,
24,
75,
76). It is known that
B. subtilis can grow and proliferate after a permanent loss of the cell wall as stable nonreverting L-forms (
1,
72). Recently, a defined
B. subtilis strain was constructed that can easily be converted from rod-shaped to L-form cells (
19,
34). In this strain, the expression of the
murE operon is under the control of a xylose-inducible promoter. The
murE operon consists of four genes—
murE,
mraY,
murD, and
spoVD—which encode enzymes involved in essential steps of cell wall precursor biosynthesis (
14). In the absence of xylose, the precursor UDP-
N-acetylmuramyl (MurNAc) pentapeptide cannot be assembled and loaded on the lipid carrier, undecaprenol phosphate (UP) (
4,
20). Under such conditions, the cells are therefore unable to synthesize the essential cell wall precursors, including lipid I and lipid II. Thus, L-forms can be conveniently generated in the absence of xylose in osmotically stabilized medium. Addition of xylose to the medium leads to normal expression of the
murE operon, resulting in correct cell wall biosynthesis and hence rod-shaped cells (
19,
34).
In
B. subtilis and other Gram-positive bacteria, the cell wall represents the first and major line of defense against environmental threats, including cell wall antibiotics. To ensure its integrity,
B. subtilis cells harbor a complex regulatory network for permanently monitoring the state of cell envelope integrity (
29). This cell envelope stress response (CESR) network consists of at least four alternative σ-factors of the extracytoplasmic function (ECF) protein family (
65) and a similar number of two-component systems (TCS) (
29).
The TCS LiaRS is strongly induced by a diverse range of antibiotics that target the bactoprenol cycle of cell wall biosynthesis, e.g., the nonribosomally synthesized cyclic dodecylpeptide antibiotic bacitracin, the lantibiotic nisin, the glycolipodepsipeptide ramoplanin, and the glycopeptide antibiotic vancomycin (
39,
40,
56,
74). It is also induced by some antimicrobial compounds directly interfering with membrane integrity, such as the antimicrobial (lipo)peptides daptomycin and LL-37 (
40,
53,
73). Although the physiological role of the Lia system in
B. subtilis is not fully understood, the target promoter P
liaI has been developed as a biosensor and also adapted for high-throughput screens, based on its strong and specific induction by a variety of peptide antibiotics interfering with cell envelope integrity (
8,
40,
64).
The BceRS system belongs to a second type of cell envelope stress-sensing TCS in
B. subtilis. It is functionally associated with a peptide antibiotic-specific detoxification pump, the ABC transporter BceAB (
2,
55). The BceRS TCS plays a central role in the bacitracin stress response, and BceAB represents the most efficient bacitracin resistance determinant in
B. subtilis (
39,
49,
55). More recently, it was shown that this module also strongly responds to some additional, chemically unrelated peptide antibiotics, such as plectasin, and the lantibiotics mersacidin and actagardine, while conferring only weak or no resistance against them (
58,
64). The specific range of inducers for the BceRSAB module led to the development of a biosensor, based on the respective target promoter P
bceA (
64).
While the LiaRS and BceRS TCS respond exclusively to antibiotics interfering with the membrane-associated steps of cell wall synthesis, the specificity by which they sense and distinguish individual peptide antibiotics is unclear, with regard to both the chemical nature of these compounds and their mechanism of action (MOA).
This functional and chemical diversity of antibiotics acting as inducers provokes the question of the exact nature of the stimuli sensed by the CESR systems LiaRS and BceRS. Are the two systems able to sense these very different compounds directly, i.e., by binding them (drug sensing)? Or is it rather some aspect of the damage caused by these compounds on the cell envelope that is ultimately detected (damage sensing)? We decided to employ B. subtilis L-forms to address these questions and also gain some deeper insight into the MOA of these antibiotics.
The genetically well-defined background of the B. subtilis strain described above should allow us to separate these effects by using identical strains, propagated either as rod-shaped cells with cell walls or as osmotically stabilized L-forms lacking the murein sacculus. Hence, this strain and the derived biosensors, based on PbceA and PliaI, should provide powerful tools for studying the mechanism of action of novel compounds targeting the cell envelope in vivo both directly, by assessing their antimicrobial activity, and indirectly, by monitoring the induction of biosensors specifically responding to peptide antibiotics that interfere with cell envelope integrity.
Our results not only establish B. subtilis L-forms as a powerful tool for MOA studies of antibiotics that target the cell envelope but also provide an insight into the nature of the stimuli sensed by the LiaRS and BceRS CESR modules.
RESULTS
The initial goal of this work was to evaluate the use of inducible L-forms of B. subtilis, based on the depletion of cell wall precursors by the repression of the murE operon in strain PDC204, as a tool for studying the MOA of cell wall antibiotics both at the level of their biological activity and at the level of induction of the established B. subtilis biosensors PliaI and PbceA. This analysis was initiated by introducing the PliaI-lacZ and PbceA-lacZ fusions into the amyE locus of strain PDC204, resulting in the reporter strains TMB1080 (PliaI) and TMB1082 (PbceA), respectively.
The L-form state dramatically alters the antibiotic sensitivity profile.
As a first test, we used antibiotic gradient diffusion plates (see Materials and Methods for details) to assess the inhibitory actions of selected cell wall antibiotics and their effects on the two biosensors, both before (rod-shaped cells) and after conversion of the strains into the L-form state. Mid-log-phase cultures of rod-shaped cells and L-forms were spotted in a line across the antibiotic gradient (
Fig. 1). After incubation, the plates were visually inspected to determine the relative inhibitory effect of the tested antibiotics on the different strains, as indicated by the point of growth inhibition on the gradient. The addition of X-Gal to these plates also provided an indication for the induction of the reporter constructs in each strain by the development of a blue coloration of the patch of bacterial growth (
Fig. 1). Since it is not possible to ensure an identical cell number's being initially spotted for the L-forms, this assay cannot be used as a quantitative measure of inhibitory action, at least for this cell type. Nevertheless, this easy-to-perform assay provided a first qualitative readout for the antimicrobial action of these compounds, due to the dramatic differences in sensitivities and regulatory response between the two strains.
While resistance against β-lactam antibiotics is well documented for L-forms, their response to antibiotics interfering with the membrane-anchored steps of cell wall biosynthesis, such as those used in this study, is less well understood. In the case of mersacidin and vancomycin, L-form colonies are fully viable, even at the highest antibiotic concentration applied (
Fig. 1). While only moderate concentrations of vancomycin (maximum, 0.06 μg ml
−1) could be used in gradient plates and still allow growth of the highly sensitivity rod-shaped wild type, we verified that L-form cultures could survive in the presence of over 10 μg ml
−1 vancomycin, demonstrating a >100-fold-increased MIC for L-forms relative to the MIC for the wild type (data not shown). This dramatically increased resistance in the absence of a cell wall indicates that the target structure for both compounds is lacking or of no consequence to viability in L-forms, which is in good agreement with the respective MOA. In contrast, L-forms are dramatically more susceptible to daptomycin and nisin (
Fig. 1), which both disrupt the integrity of the cytoplasmic membrane.
While L-forms are more resistant to bacitracin then their corresponding wild-type cells, they nevertheless retain a certain degree of susceptibility at higher antibiotic concentrations (
Fig. 1). The primary inhibitory effect is a specific binding of bacitracin to undecaprenol pyrophosphate, thereby preventing its recycling to the monophosphate form, UP (
66,
67). Hence, the cellular pool of UP, an essential precursor of the lipid II cycle, is rapidly depleted, thereby ultimately stopping cell wall biosynthesis. While this step is no longer essential in L-forms, our observation is in agreement with earlier reports demonstrating that bacitracin can also interfere with membrane integrity, i.e., by disrupting protoplasts (summarized in reference
46). However, the exact mechanism for this interference has not yet been elucidated.
In contrast, no significantly altered sensitivity was observed for the translational inhibitor kanamycin or the DNA-intercalating agent phleomycin (data not shown), demonstrating that the observed effects are indeed cell wall specific, as expected.
Taken together, our results demonstrate that the susceptibility of B. subtilis against antibiotics that inhibit membrane-anchored steps of cell wall biosynthesis is strongly affected. The hypersensitivity obtained in L-forms treated with nisin and daptomycin also indicates that L-forms represent a useful tool to distinguish between cell wall and membrane perturbation and to identify potential secondary MOAs. Moreover, our results suggest that both nisin and daptomycin might be potent drugs against persistent infections with pathogenic L-forms.
The response of cell wall antibiotic biosensors is altered in L-forms.
Since classical disk diffusion assays (
10,
64) could not be successfully adapted for L-forms (data not shown), we instead modified the gradient plates described above for this purpose. Addition of the chromogenic β-galactosidase substrate X-Gal allowed direct assessment of the response of the LiaRS- and BceRS-dependent promoters in both the rod-shaped and L-form states as a function of the antibiotic concentration. In analogy to the disk diffusion assay, the strongest response of our wild-type biosensors was observed in colonies spotted at the highest tolerated concentrations (
Fig. 1). Unfortunately, the intensity of the blue color was significantly weaker on gradient plates than in disk diffusion assays. Moreover, the strength of coloration does not directly correlate with induction strength but is instead reporter strain dependent, as noted in previous studies (
11,
40,
64). Nevertheless, we observed a clear blue color for the L-forms containing P
bceA in the presence of suitable amounts of both bacitracin and mersacidin (
Fig. 1A), which are known inducers of the Bce system (
64). The induction of the P
liaI-derived reporter, which already provides a much weaker readout in disk diffusion assays (our unpublished data), is harder to detect on gradient plates. Nevertheless, a reproducible formation of light blue colonies at the highest tolerated concentrations can be observed for rod-shaped wild-type colonies in the presence of four of the five known inducers tested (
Fig. 1B). In the case of daptomycin, the lack of a signal correlates with a lack of inhibition of rod-shaped cells even at the highest concentrations, indicative of insufficient antibiotic concentration. However, higher concentrations could not be used, since they completely prevented the growth of the corresponding L-form colonies (data not shown).
The BceR-dependent reporter strain TMB1082 showed comparable promoter activities in both wild-type and the corresponding L-form colonies in response to bacitracin and mersacidin (
Fig. 1A). Interestingly, the minimal inducing concentrations for the two cell types were identical, irrespective of the significant differences in sensitivity, as described above. In contrast, no induction could be observed in L-form colonies of the LiaRS-dependent biosensor TMB1080 (
Fig. 1B).
Our results therefore demonstrate that gradient plate experiments using the established biosensors PbceA and PliaI can be applied as a first comparative and qualitative screen for antibiotic induction, both in rod-shaped wild-type and in L-form colonies. Importantly, these initial results indicate that the response of the PbceA-derived reporter strain is unaffected by the absence of a cell wall and therefore the damage caused by these antibiotics, indicative of a more direct sensing of the two compounds. In contrast, the PliaI-based reporter no longer seems to respond to its known inducers in the L-forms, which can be interpreted as a more indirect, damage-induced sensing of antibiotic action. However, the low sensitivity in case of PliaI of the assay and the narrow range of concentrations that can be tested are significant limitations of this method. Hence, a more sensitive and quantitative measure is necessary to support these initial observations.
Promoter activity in L-forms can be quantified by β-galactosidase assay.
B. subtilis strains carrying fusions of reporter genes to P
bceA and P
liaI have proven to be valuable biosensors for the study of antibiotics that interfere with the membrane-anchored steps of cell wall biosynthesis (
8,
40,
64). The gradient plate experiments described above indicated that the classical
lacZ-based reporter gene fusions can also be used in L-forms (
Fig. 1). We therefore next aimed at establishing the classical β-galactosidase assay for liquid cultures of
B. subtilis L forms to further develop and evaluate the use of promoter-based biosensors in this genetic background. This type of assay has traditionally been normalized by expressing the enzyme activities relative to cell density (
44). Hence, we first verified that measuring the OD
600 is also a reliable measure for liquid L-form cultures by demonstrating a linear correlation of total protein concentration with optical density (data not shown).
Next, we investigated if β-galactosidase assays can be applied to L-forms to quantitatively monitor gene expression in these cell wall-deficient bacteria. For this purpose, we measured the promoter activity in strains TMB1080 (P
liaI) and TMB1082 (P
bceA) in both rod-shaped cells and their corresponding L-forms. As inducers, only bacitracin and mersacidin were chosen for these in-depth studies, since they are the only two compounds that activate both systems in wild-type cells (
64). Samples of mid-logarithmic-phase cultures were split into three aliquots: one was an uninduced reference sample, and the other two were induced, one with bacitracin (50 μg ml
−1) and one with mersacidin (5 μg ml
−1). Because of the significantly reduced growth (and hence also protein production) rate of L-forms, it was critical to adjust the incubation time postinduction to 4 h (instead of the usual 30 min for wild-type cultures). This incubation time did not affect the basal promoter activity but resulted in significantly increased activities after antibiotic induction (data not shown). After 30 min or 4 h, the cells of wild-type or L-form cultures, respectively, were harvested and subjected to β-galactosidase assays as described in Materials and Methods. The results are shown in
Fig. 2A. Rod-shaped wild type cells containing either P
bceA-
lacZ (TMB1082) or P
liaI-
lacZ (TMB1080) responded strongly to the presence of bacitracin and mersacidin, as expected (
Fig. 2A) (
64). In the corresponding L forms, the overall background activity was higher than in the wild type for both biosensors (
Fig. 2A). No induction of P
liaI activity was observed in strain TMB1080 after 4 h of incubation in the presence of bacitracin and mersacidin. In contrast, TMB1082 (P
bceA-
lacZ) showed five- and sevenfold-increased β-galactosidase activities for bacitracin and mersacidin, respectively (
Fig. 2A). These data are in good agreement with the results obtained with gradient plates (
Fig. 1). Inhibitors of translation did not induce either of the biosensors, as expected, thereby demonstrating the specificity of the responses in both rods and L-forms (data not shown).
To verify our data, we next analyzed the transcription of
liaI and
bceA directly by quantitative real-time RT-PCR, using RNA prepared from wild-type and L-form cultures of strain PDC134 after treatment of the cells for 30 min with bacitracin. RNA from an uninduced culture was prepared in parallel as a reference. Bacitracin strongly induced the expression of both genes in wild-type cells (>150- to 200-fold relative to the basal expression level) (
Fig. 2B), as expected. Moreover, a clear induction of
bceA expression was also observed in the L-form sample (∼40-fold). In contrast, no significant induction of
liaI can be detected in L-forms containing P
liaI-
lacZ. For TMB1080, we also tested the activity of P
liaI in the presence of other known inducers, such as vancomycin and nisin. Again, P
liaI responded to both antibiotics in the wild type, as described previously (
40), while no induction of the
liaI promoter was observed in the derived L-forms (data not shown). The lower induction ratio for
bceA in the L-form samples was due to an overall higher basal signal, as was observed by β-galactosidase assay (
Fig. 2A). The overall higher dynamic range determined by quantitative real-time RT-PCR is commonly observed, due to the higher sensitivity of this assay. Thus, the quantitative real-time RT-PCR results are in perfect agreement with the observations from both gradient plates and liquid β-galactosidase assays.